Solid Biosciences logo

Solid Biosciences Share Price (NASDAQ: SLDB)

$5.48

-0.14

(-2.49%)

Last updated on

Check the interactive Solid Biosciences Stock chart to analyse performance

Solid Biosciences stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$5.37
    Today's High:$5.63

    Day's Volatility :4.62%

  • 52 Weeks Low:$2.41
    52 Weeks High:$9.04

    52 Weeks Volatility :73.34%

Solid Biosciences Stock Returns

PeriodSolid Biosciences IncRussel 2000Index (Russel 2000)
3 Months
54.52%
0.0%
0.0%
6 Months
6.84%
0.0%
0.0%
1 Year
-35.42%
0.0%
0.0%
3 Years
-44.75%
-4.1%
-4.1%

Solid Biosciences Inc Key Stats

Check Solid Biosciences key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$5.62
Open
$5.63
Today's High
$5.63
Today's Low
$5.37
Market Capitalization
$437.6M
Today's Volume
$508.1K
52 Week High
$9.04
52 Week Low
$2.41
Revenue TTM
$0.0
EBITDA
$-155.1M
Earnings Per Share (EPS)
$-2.79
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-68.25%

Stock Returns calculator for Solid Biosciences Stock including INR - Dollar returns

The Solid Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Solid Biosciences investment value today

Current value as on today

₹69,983

Returns

₹30,017

(-30.02%)

Returns from Solid Biosciences Stock

₹35,301 (-35.3%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Solid Biosciences Stock

-33%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Solid Biosciences Stock from India on INDmoney has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Solid Biosciences Inc

  • Name

    Holdings %

  • Perceptive Advisors LLC

    15.34%

  • Bain Capital Life Sciences Investors, LLC

    10.20%

  • Siren, L.L.C.

    9.56%

  • Adage Capital Partners Gp LLC

    8.67%

  • RA Capital Management, LLC

    7.49%

  • FMR Inc

    4.53%

Analyst Recommendation on Solid Biosciences Stock

Rating
Trend

Buy

    80%Buy

    20%Hold

    0%Sell

Based on 15 Wall street analysts offering stock ratings for Solid Biosciences(by analysts ranked 0 to 5 stars)

Solid Biosciences Share Price Target

What analysts predicted

Upside of 184.37%

Target:

$15.58

Current:

$5.48

Solid Biosciences share price target is $15.58, a slight Upside of 184.37% compared to current price of $5.48 as per analysts' prediction.

Solid Biosciences Stock Insights

  • Price Movement

    In the last 7 days, SLDB stock has moved down by -7.8%
  • SLDB vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 108.6%
  • SLDB vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 159.0%

Solid Biosciences Technicals Summary

Sell

Neutral

Buy

Solid Biosciences is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Solid Biosciences Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Solid Biosciences Inc logo
-19.91%
6.84%
-35.42%
-44.75%
-84.28%
Regeneron Pharmaceuticals, Inc. logo
3.92%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
2.49%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-15.42%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
11.08%
83.28%
75.87%
111.28%
242.25%

About Solid Biosciences Inc

Solid Biosciences Inc. develops therapies for neuromuscular and cardiac diseases in the United States. The company's lead product candidate is SGT-003, which is in phase 1/2 for the treatment of Duchenne muscular dystrophy. It also develops SGT-212 for the treatment of Friedreich's ataxia that is in phase 1b clinical trial; SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia that is in preclinical phase; SGT-601 the treatment of TNNT2-mediated dilated cardiomyopathy, which is in preclinical phase; SGT-401 for the treatment of BAG3-mediated dilated cardiomyopathy that is in preclinical phase; SGT-701 for treatment of rare inherited disease characterized by mutations in the RBM20 gene, which is in discovery phase; and other drugs for the treatment of cardiac and other diseases. In addition, the company is involved in developing platform technologies, including capsid libraries; genetic regulators, such as promoters, UTRs, and introns; immunomodulation technologies; manufacturing purity; and dual gene expression, a technology for packaging multiple transgenes into one capsid. The company has collaboration and license agreement with Ultragenyx Pharmaceutical Inc.; and a license agreement with the University of Washington, University of Missouri, University of Florida, and ICS Maugeri S.p.A. Solid Biosciences Inc. was incorporated in 2013 and is headquartered in Charlestown, Massachusetts.
Organization
Solid Biosciences
Employees
100
CEO
Mr. Alexander G. Cumbo
Industry
Health Technology

Key Management of Solid Biosciences Inc

NameTitle
Mr. Ian F. Smith A.C.A., C.P.A.
Executive Chair
Mr. Alexander G. Cumbo
President, CEO & Director
Mr. Ilan Ganot
Co-founder, Strategic Advisor to the CEO & Director
Mr. David Tyronne Howton Jr., J.D.
COO & Secretary
Dr. Gabriel Brooks M.D.
Chief Medical Officer
Ms. Annie Ganot
Co-Founder & VP of Patient Advocacy
Mr. Kevin Tan C.F.A.
CFO & Treasurer
Mr. Paul Herzich
Chief Technology Officer
Ms. Nicole Anderson
Director of Investor Relations & Corporate Communications
Ms. Allison Bogosian J.D.
Senior Vice President of Human Resources

Important FAQs about investing in SLDB Stock from India :

What is Solid Biosciences share price today?

Solid Biosciences share price today is $5.48 as on at the close of the market. Solid Biosciences share today touched a day high of $5.63 and a low of $5.37.

What is the 52 week high and 52 week low for Solid Biosciences share?

Solid Biosciences share touched a 52 week high of $9.04 and a 52 week low of $2.41. Solid Biosciences stock price today i.e. is closed at $5.48, lower by 39.38% versus the 52 week high.

How to invest in Solid Biosciences Stock (SLDB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Solid Biosciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Solid Biosciences Shares that will get you 0.2737 shares as per Solid Biosciences share price of $5.48 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Solid Biosciences Stock (SLDB) from India?

Indian investors can start investing in Solid Biosciences (SLDB) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Solid Biosciences stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Solid Biosciences share’s latest price of $5.48 as on August 30, 2025 at 1:29 am IST, you will get 1.8248 shares of Solid Biosciences. Learn more about fractional shares .

What are the returns that Solid Biosciences has given to Indian investors in the last 5 years?

Solid Biosciences stock has given -84.28% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?